Related Experiment Videos
Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized children
Insights
Vecuronium and pancuronium have similar elimination half-lives in children. Vecuronium
Area of Science:
- Pediatric Anesthesiology
- Pharmacology
- Clinical Chemistry
Background:
- Neuromuscular blocking agents are essential in pediatric anesthesia.
- Vecuronium and pancuronium are commonly used non-depolarizing neuromuscular blockers.
- Understanding their pharmacokinetic profiles in children is crucial for safe and effective use.
Purpose of the Study:
- To compare the pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in pediatric patients.
- To elucidate the reasons for potential differences in their duration of action in children.
Main Methods:
- Pharmacokinetic analysis of vecuronium and pancuronium in 12 children (3-6 yr) undergoing surgery.
- Intravenous administration of 100 mcg/kg of either drug under halothane anesthesia.
- Plasma drug concentrations measured via fluorimetric assay and thin-layer chromatography for 6 hours.
- Electromyography (EMG) used to assess neuromuscular blockade recovery.
Main Results:
- Both drugs exhibited biexponential decline in plasma concentrations without detectable metabolites.
- Elimination half-lives were not significantly different between vecuronium and pancuronium.
- Vecuronium showed a significantly greater volume of distribution (Vdss) and plasma clearance compared to pancuronium.
- No significant differences in plasma concentrations at varying EMG recovery levels were observed.
Conclusions:
- Vecuronium's shorter duration of action in children is likely attributed to its larger volume of distribution and higher plasma clearance, not its elimination half-life.
- Despite comparable elimination half-lives, vecuronium exhibits more rapid plasma disappearance than pancuronium in pediatric patients.
Abstract:
The pharmacokinetics and pharmacodynamics of vecuronium and pancuronium were determined in 12 children (3-6 yr) undergoing minor surgery under 60% nitrous oxide, 1 MAC halothane anesthesia. When the level of anesthesia and the electromyograph (EMG) recording of the adductor pollicis were stable, an intravenous bolus of vecuronium (100 micrograms/kg) or pancuronium (100 micrograms/kg) was administered. Plasma concentrations of the two muscle relaxants were determined for 6 hr after the administration by means of a fluorimetric assay followed by a thin layer chromatography. Plasma concentrations of vecuronium and pancuronium declined biexponentially in children and no metabolites could be detected in plasma. The elimination half-lives of vecuronium and pancuronium did not differ significantly. The volume of distribution at steady state (Vdss) was greater (P less than 0.05) after vecuronium (320 +/- 181 ml/kg; mean +/- SD) than after pancuronium (203 +/- 36 ml/kg). Plasma clearance of vecuronium (2.8 +/- 0.9 ml X min-1 X kg-1) was greater than that of pancuronium (1.7 +/- 0.2 ml X min-1 X kg-1; P less than 0.05). Plasma concentrations measured at 10%, 50%, or 90% recovery of the EMG response did not differ significantly for vecuronium and pancuronium. Thus the shorter duration of action of vecuronium is probably due to its greater apparent volume of distribution, as well as to its higher plasma clearance. Thus although the elimination half-lives are comparable, the plasma disappearance of vecuronium is more rapid than that of pancuronium.